Trial Profile
A study to compare the prasugrel and adjunctive cilostazol to dual anti-platelet therapy in patients with ST segment elevation myocardial infarction.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Aspirin; Cilostazol; Clopidogrel
- Indications Myocardial infarction
- Focus Therapeutic Use
- 23 Dec 2015 New trial record